SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling

Abstract

Summary: The immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteome is largely unknown. Here we describe a protocol for analyzing sera samples with SARS-CoV-2 proteome microarray. The proteins were expressed by either E. coli expression system or eukaryotic cell expression systems and obtained by affinity purification. The protocol includes microarray fabricating and sera profiling, which will be used to build an antibody response landscape for IgG and IgM. The protocol may help to facilitate a deeper understanding of immunity related to SARS-CoV-2.For complete details on the use and execution of this protocol, please refer to Li et al. (2021c).

Keywords

• Health Sciences
• Clinical Protocol
• Immunology
• Protein Biochemistry
• Proteomics
• Protein expression and purification